HPV DNA testing in cervical cancer screening: from evidence to policies.

作者信息

Cox Tom, Cuzick Jack

机构信息

Health Services, University of California Santa Barbara, Santa Barbara, CA 93460, USA.

出版信息

Gynecol Oncol. 2006 Oct;103(1):8-11. doi: 10.1016/j.ygyno.2006.07.030. Epub 2006 Aug 21.

DOI:10.1016/j.ygyno.2006.07.030

PMID:16919716

Abstract

摘要

相似文献

HPV DNA testing in cervical cancer screening: from evidence to policies.

Gynecol Oncol. 2006 Oct;103(1):8-11. doi: 10.1016/j.ygyno.2006.07.030. Epub 2006 Aug 21.

HPV primary screening for cervical cancer: more pain than protection.

Diagn Cytopathol. 2000 Jun;22(6):333-5. doi: 10.1002/(sici)1097-0339(200006)22:6<333::aid-dc1>3.0.co;2-8.

HPV DNA testing for cervical cancer screening. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S239-46. doi: 10.1016/S0020-7292(06)60039-8.

[HPV testing--weak justification for controversial decision].

Tidsskr Nor Laegeforen. 2012 Jun 26;132(12-13):1476-8. doi: 10.4045/tidsskr.12.0542.

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.

JAMA. 2002 Oct 9;288(14):1749-57. doi: 10.1001/jama.288.14.1749.

HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.

JAMA. 2000 Jan 5;283(1):81-6. doi: 10.1001/jama.283.1.81.

[Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].

Zhonghua Zhong Liu Za Zhi. 2020 Mar 23;42(3):252-256. doi: 10.3760/cma.j.cn112152-20190603-00346.

Human Papillomavirus DNA detection for cervical cancer screening.

Mol Diagn. 2000 Sep;5(3):245-7.

Human papillomavirus DNA in cervical lesions from Morocco and its implications for cancer control.

Clin Microbiol Infect. 2003 Feb;9(2):144-8. doi: 10.1046/j.1469-0691.2003.00494.x.

Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.

J Natl Cancer Inst. 2009 Jan 21;101(2):88-99. doi: 10.1093/jnci/djn444. Epub 2009 Jan 13.

引用本文的文献

Comparison of four different human papillomavirus genotyping methods in cervical samples: Addressing method-specific advantages and limitations.

Heliyon. 2024 Jan 30;10(3):e25474. doi: 10.1016/j.heliyon.2024.e25474. eCollection 2024 Feb 15.

Diagnostic Value of the CareTM HPV Test in Screening for Cervical Intraepithelial Neoplasia Grade 2 or Worse.

Asian Pac J Cancer Prev. 2017 Mar 1;18(3):687-693. doi: 10.22034/APJCP.2017.18.3.687.

The high prevalence of HPV and HPV16 European variants in cervical and anal samples of HIV-seropositive women with normal Pap test results.

PLoS One. 2017 Apr 20;12(4):e0176422. doi: 10.1371/journal.pone.0176422. eCollection 2017.

Human papillomavirus genotypes distribution among Gabonese women with normal cytology and cervical abnormalities.

Infect Agent Cancer. 2016 Jan 15;11:2. doi: 10.1186/s13027-016-0046-0. eCollection 2016.

Key considerations and current perspectives of epidemiological studies on human papillomavirus persistence, the intermediate phenotype to cervical cancer.

Int J Infect Dis. 2013 Apr;17(4):e216-20. doi: 10.1016/j.ijid.2012.12.027. Epub 2013 Feb 27.

mRNA and DNA detection of human papillomaviruses in women of all ages attending two colposcopy clinics.

PLoS One. 2012;7(11):e49205. doi: 10.1371/journal.pone.0049205. Epub 2012 Nov 15.

Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix.

J Clin Microbiol. 2009 Dec;47(12):3895-901. doi: 10.1128/JCM.01275-09. Epub 2009 Oct 14.

RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus.

J Clin Microbiol. 2009 Jul;47(7):2136-41. doi: 10.1128/JCM.01733-08. Epub 2009 Apr 29.

The impact of human papillomavirus information on perceived risk of cervical cancer.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):373-6. doi: 10.1158/1055-9965.EPI-08-0357. Epub 2009 Feb 3.

Sociodemographic predictors of HPV testing and vaccination acceptability: results from a population-representative sample of British women.

J Med Screen. 2008;15(2):91-6. doi: 10.1258/jms.2008.008011.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验